Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

BACKGROUND: Mycobacterium abscessus (M. abscessus) pulmonary disease is a refractory chronic infectious disease. Options for treating M. abscessus pulmonary disease are limited, especially in outpatient settings. Among parenteral antibiotics against M. abscessus, intravenous amikacin (AMK) is expect...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Infect Dis
Hoofdauteurs: Namkoong, Ho, Morimoto, Kozo, Nishimura, Tomoyasu, Tanaka, Hiromu, Sugiura, Hiroaki, Yamada, Yoshitake, Kurosaki, Atsuko, Asakura, Takanori, Suzuki, Shoji, Fujiwara, Hiroshi, Yagi, Kazuma, Ishii, Makoto, Tasaka, Sadatomo, Betsuyaku, Tomoko, Hoshino, Yoshihiko, Kurashima, Atsuyuki, Hasegawa, Naoki
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977760/
https://ncbi.nlm.nih.gov/pubmed/27506679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1689-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items